Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients-Reference-Cited by-同舟云学术

Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients

Published:2016-01-25 Issue:1 Volume:11 Page:e0146272
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wouters Hans,Van Dijk Liset,Geers Harm C. J.,Winters Nina A.,Van Geffen Erica C. G.,Stiggelbout Anne M.,Bouvy Marcel L.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Non-adherence to statin therapy: a major challenge for preventive cardiology;TR Bates,2009

2. Adherence to medication;L Osterberg,2005

3. Antidepressants in primary care: patients' experiences, perceptions, self-efficacy beliefs, and nonadherence;H Wouters,2014

4. Endocrine Therapy for Breast Cancer: Assessing an Array of Women's Treatment Experiences and Perceptions, Their Perceived Self-Efficacy and Nonadherence;H Wouters,2014

5. Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes;U Khanderia,2008

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease;Reviews in Cardiovascular Medicine;2024-05-23

2. Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of Cardiology;Archives of Cardiovascular Diseases;2024-05

3. Online health information behaviour and its association with statin adherence in patients with high cardiovascular risk: A prospective cohort study;DIGITAL HEALTH;2024-01

4. Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study;Cardiology and Therapy;2023-10-07

5. Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore;BMJ Open;2023-09